Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Rosuvastatin on Immunological Markers After Traumatic Brain Injury: Clinical Randomized Double Blind Study Phase 2

NCT00990028 is registered in ClinicalTrials.gov with Universidad Autonoma de San Luis Potosí as lead sponsor.

NCT NCT00990028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00990028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Rosuvastatin on Immunological Markers After Traumatic Brain Injury: Clinical Randomized Double Blind Study Phase 2
Lead sponsor
Universidad Autonoma de San Luis Potosí
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2009
Completion date
August 31, 2011
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head injury